-
Something wrong with this record ?
A rat model of early sepsis: relationships between gentamicin pharmacokinetics and systemic and renal effects of bacterial lipopolysaccharide combined with interleukin-2
S. Studena, J. Martinkova, D. Slizova, O. Krs, M. Senkerik, D. Springer, J. Chládek,
Language English Country Japan
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1993
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - English
from 1993
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - English
from 1993
Open Access Digital Library
from 1993-01-01
PubMed
23037160
DOI
10.1248/bpb.b12-00205
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents blood pharmacokinetics urine MeSH
- Gentamicins blood pharmacokinetics urine MeSH
- Glomerular Filtration Rate drug effects MeSH
- Interleukin-2 administration & dosage MeSH
- Capillary Permeability drug effects MeSH
- Rats MeSH
- Kidney drug effects metabolism physiopathology MeSH
- Lipopolysaccharides administration & dosage MeSH
- Disease Models, Animal * MeSH
- Rats, Wistar MeSH
- Sepsis metabolism physiopathology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
A rat model of early sepsis induced by lipopolysaccharide (LPS) combined with interleukin-2 (IL-2) was developed. The primary aim was to assess the pharmacokinetics of gentamicin and sepsis-induced pathophysiological changes. Moreover, the effects on the glomerular filtration rate and tubular function were studied in septic and control rats. First, an intravenous (i.v.) bolus of LPSIL-2 (1 mg/kg-Pseudomonas aeruginosa, 15 µg/kg IL-2) or saline (controls, C) was administred. The Wistar rats were treated 30 min after LPSIL-2 with gentamicin as a 3 mg/kg i.v. bolus followed 10 min later by an i.v. 170-min infusion (GE, 0.09 mg/kg·min(-1)). The monitoring of vital functions, biochemistry and GE concentrations was performed. Creatinine clearance was 2-3 times lower and fractional urea excretion was 3-4 times less in septic rats as compared to controls(p<0.05), although urine flow was comparable. Capillary leakage caused a 55% elevation in the volume of distribution (V(c)) in the LPSIL+GE group vs. C+GE (p<0.05). The renal CL(ge) was less (2.2±0.59 vs. 3.8±0.53 mL/min·kg(-1), p<0.05), while the total CL(ge) was comparable (5.9±1.5 vs. 6.7±1.1 mL/min·kg(-1); p=0.30). In the LPSIL+GE group relative to C+GE, the half-life (t(1/2)) was 79% higher (p<0.05) and GE concentrations detected at the end of the study in the plasma and kidney were elevated 2.5-fold (p=0.09) and 2.2-fold (p<0.05), respectively. The model reproduced several consequences of early sepsis like in patients such as capillary leak, a decreased glomerular filtration rate (GFR) and the changes in pharmacokinetics of GE (increased values of V(c) and t(1/2) and a drop in renal CL(ge) proportional to that of CL(cr)). Nonrenal routes which, for the most part, compensate the reduced renal CL(ge) in septic rats deserve further study.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012407
- 003
- CZ-PrNML
- 005
- 20130410094012.0
- 007
- ta
- 008
- 130404s2012 ja f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1248/bpb.b12-00205 $2 doi
- 035 __
- $a (PubMed)23037160
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ja
- 100 1_
- $a Studena, Sarka $u Department of Pharmacology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Czech Republic.
- 245 12
- $a A rat model of early sepsis: relationships between gentamicin pharmacokinetics and systemic and renal effects of bacterial lipopolysaccharide combined with interleukin-2 / $c S. Studena, J. Martinkova, D. Slizova, O. Krs, M. Senkerik, D. Springer, J. Chládek,
- 520 9_
- $a A rat model of early sepsis induced by lipopolysaccharide (LPS) combined with interleukin-2 (IL-2) was developed. The primary aim was to assess the pharmacokinetics of gentamicin and sepsis-induced pathophysiological changes. Moreover, the effects on the glomerular filtration rate and tubular function were studied in septic and control rats. First, an intravenous (i.v.) bolus of LPSIL-2 (1 mg/kg-Pseudomonas aeruginosa, 15 µg/kg IL-2) or saline (controls, C) was administred. The Wistar rats were treated 30 min after LPSIL-2 with gentamicin as a 3 mg/kg i.v. bolus followed 10 min later by an i.v. 170-min infusion (GE, 0.09 mg/kg·min(-1)). The monitoring of vital functions, biochemistry and GE concentrations was performed. Creatinine clearance was 2-3 times lower and fractional urea excretion was 3-4 times less in septic rats as compared to controls(p<0.05), although urine flow was comparable. Capillary leakage caused a 55% elevation in the volume of distribution (V(c)) in the LPSIL+GE group vs. C+GE (p<0.05). The renal CL(ge) was less (2.2±0.59 vs. 3.8±0.53 mL/min·kg(-1), p<0.05), while the total CL(ge) was comparable (5.9±1.5 vs. 6.7±1.1 mL/min·kg(-1); p=0.30). In the LPSIL+GE group relative to C+GE, the half-life (t(1/2)) was 79% higher (p<0.05) and GE concentrations detected at the end of the study in the plasma and kidney were elevated 2.5-fold (p=0.09) and 2.2-fold (p<0.05), respectively. The model reproduced several consequences of early sepsis like in patients such as capillary leak, a decreased glomerular filtration rate (GFR) and the changes in pharmacokinetics of GE (increased values of V(c) and t(1/2) and a drop in renal CL(ge) proportional to that of CL(cr)). Nonrenal routes which, for the most part, compensate the reduced renal CL(ge) in septic rats deserve further study.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $x krev $x farmakokinetika $x moč $7 D000900
- 650 _2
- $a kapilární permeabilita $x účinky léků $7 D002199
- 650 12
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a gentamiciny $x krev $x farmakokinetika $x moč $7 D005839
- 650 _2
- $a hodnoty glomerulární filtrace $x účinky léků $7 D005919
- 650 _2
- $a interleukin-2 $x aplikace a dávkování $7 D007376
- 650 _2
- $a ledviny $x účinky léků $x metabolismus $x patofyziologie $7 D007668
- 650 _2
- $a lipopolysacharidy $x aplikace a dávkování $7 D008070
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a sepse $x metabolismus $x patofyziologie $7 D018805
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Martinkova, Jirina $u -
- 700 1_
- $a Slizova, Dasa $u -
- 700 1_
- $a Krs, Otakar $u -
- 700 1_
- $a Senkerik, Marian $u -
- 700 1_
- $a Springer, Drahomira $u -
- 700 1_
- $a Chládek, Jaroslav $u -
- 773 0_
- $w MED00000729 $t Biological & pharmaceutical bulletin $x 1347-5215 $g Roč. 35, č. 10 (2012), s. 1703-10
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23037160 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20130410094241 $b ABA008
- 999 __
- $a ok $b bmc $g 975605 $s 810688
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 35 $c 10 $d 1703-10 $i 1347-5215 $m Biological & pharmaceutical bulletin $n Biol Pharm Bull $x MED00000729
- LZP __
- $a Pubmed-20130404